Abstract: Provided is a secure communication control system. The secure communication control system comprises a guest control unit provided in a guest operating system for generating a thread requesting arbitrary data from a host application installed in a host operating system; a guest shared key generation unit for generating a guest shared key to be used in the thread; a guest communication unit for transmitting the thread and the guest shared key to the host operating system; a host shared key generation unit for generating a host shared key corresponding to the guest shared key; a host control unit for requesting data according to the thread from the host application to receive the data from the host application, generating a session key from the guest shared key, and generating cipher text by encrypting the data using the session key; and a host communication unit for transmitting the cipher text and the host shared key to the guest operating system.

Abstract: The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. The receptor modulators can be formulated to form pharmaceutical compositions comprising the disclosed compounds or pharmaceutically acceptable salts or prodrugs thereof. The compositions may be used for managing CXCR4 related conditions, typically prevention or treatment of viral infections abnormal cellular proliferation, retinal degeneration, inflammatory diseases, or as an immunostimulant or immunosuppressant or for managing cancer and may be administered with another active ingredient such as an antiviral agent or chemotherapeutic agent.

Abstract: Provided is a secure communication control system. The secure communication control system comprises a guest control unit provided in a guest operating system for generating a thread requesting arbitrary data from a host application installed in a host operating system; a guest shared key generation unit for generating a guest shared key to be used in the thread; a guest communication unit for transmitting the thread and the guest shared key to the host operating system; a host shared key generation unit for generating a host shared key corresponding to the guest shared key; a host control unit for requesting data according to the thread from the host application to receive the data from the host application, generating a session key from the guest shared key, and generating cipher text by encrypting the data using the session key; and a host communication unit for transmitting the cipher text and the host shared key to the guest operating system.

Abstract: An apparatus includes a first glass plate, and an outer layer disposed over the first glass plate. The first glass plate and the outer layer are configured to hold a semiconductor die disposed on the first glass plate, and a solder preform interposed between the semiconductor die and the outer layer. The solder preform is viewable through the first glass plate.

Abstract: The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. The receptor modulators can be formulated to form pharmaceutical compositions comprising the disclosed compounds or pharmaceutically acceptable salts or prodrugs thereof. The compositions may be used for managing CXCR4 related conditions, typically prevention or treatment of viral infections abnormal cellular proliferation, retinal degeneration, inflammatory diseases, or as an immunostimulant or immunosuppressant or for managing cancer and may be administered with another active ingredient such as an antiviral agent or chemotherapeutic agent.

Abstract: The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. The receptor modulators can be formulated to form pharmaceutical compositions comprising the disclosed compounds or pharmaceutically acceptable salts or prodrugs thereof. The compositions may be used for managing CXCR4 related conditions, typically prevention or treatment of viral infections abnormal cellular proliferation, retinal degeneration, inflammatory diseases, or as an immunostimulant or immunosuppressant or for managing cancer and may be administered with another active ingredient such as an antiviral agent or chemotherapeutic agent.

Abstract: The technology described in this document can be embodied in a method for verifying an authenticated state of a device. In one aspect, the method includes capturing, during a primary authentication process, first auxiliary user identifying information for short-term authentication verification of the subject. The first auxiliary user identifying information includes first eyebrow biometric information for the subject and first eyeglass frame information for the subject. A short-term authentication verification process is performed to verify identify of the subject. In response to determining that a match score that indicates a degree of match between the first auxiliary user identifying information and captured second auxiliary user identifying information meets or exceeds a predetermined threshold, an authenticated state for the subject is verified. In response to determining that the match score does not meet or exceed the predetermined threshold, the authenticated state for the subject is ended.

Abstract: The technology described in this document can be embodied in a method for verifying an authenticated state of a device. In one aspect, the method includes capturing, during a primary authentication process, first auxiliary user identifying information for short-term authentication verification of the subject. The first auxiliary user identifying information includes first eyebrow biometric information for the subject and first eyeglass frame information for the subject. A short-term authentication verification process is performed to verify identify of the subject. In response to determining that a match score that indicates a degree of match between the first auxiliary user identifying information and captured second auxiliary user identifying information meets or exceeds a predetermined threshold, an authenticated state for the subject is verified. In response to determining that the match score does not meet or exceed the predetermined threshold, the authenticated state for the subject is ended.

Abstract: The technology described in this document can be embodied in a method for verifying an authenticated state of a device. In one aspect, the method includes capturing, during a primary authentication process, first auxiliary user identifying information for short-term authentication verification of the subject. The first auxiliary user identifying information includes first eyebrow biometric information for the subject and first eyeglass frame information for the subject. A short-term authentication verification process is performed to verify identify of the subject. In response to determining that a match score that indicates a degree of match between the first auxiliary user identifying information and captured second auxiliary user identifying information meets or exceeds a predetermined threshold, an authenticated state for the subject is verified. In response to determining that the match score does not meet or exceed the predetermined threshold, the authenticated state for the subject is ended.

Abstract: The technology described in this document can be embodied in a method for verifying an authenticated state of a device. In one aspect, the method includes capturing, during a primary authentication process, first auxiliary user identifying information for short-term authentication verification of the subject. The first auxiliary user identifying information includes first eyebrow biometric information for the subject and first eyeglass frame information for the subject. A short-term authentication verification process is performed to verify identify of the subject. In response to determining that a match score that indicates a degree of match between the first auxiliary user identifying information and captured second auxiliary user identifying information meets or exceeds a predetermined threshold, an authenticated state for the subject is verified. In response to determining that the match score does not meet or exceed the predetermined threshold, the authenticated state for the subject is ended.

Abstract: The disclosure relates to chemokine CXCR4 receptor modulators and uses related thereto. The receptor modulators can be formulated to form pharmaceutical compositions comprising the disclosed compounds or pharmaceutically acceptable salts or prodrugs thereof. The compositions may be used for managing CXCR4 related conditions, typically prevention or treatment of viral infections abnormal cellular proliferation, retinal degeneration, inflammatory diseases, or as an immunostimulant or immunosuppressant or for managing cancer and may be administered with another active ingredient such as an antiviral agent or chemotherapeutic agent.